Irving Levin Associates, Inc. Publisher

Reliable and timely business intelligence on M&A and finance in health care and seniors housing

Home | Publications | Resource Center | Database | Free Trials | Conference | Order | Senior Care Blog | Search | Contact Us 1-800-248-1668
 

We will not sell or trade your email--ever.    Privacy Policy

The Health Care M&A Monthly

In the September 2006 issue:

Mylan Buys Matrix For $736 million: Buys Indian Firm To Enter Asian and European Markets
Mylan Laboratories is expanding into Asian and European pharmaceutical markets with its $736 million purchase of a 71.5% interest in India’s Matrix Laboratories. This deal vertically integrates Mylan’s finished dosage operations with Matrix’s API business, and lowers Mylan’s cost structure.
...
The Month In Deals
August posted 68 mergers and acquisitions in the health care industry. Based on revealed prices, a total of $4.0 billion was spent to fund them. Deals in the health care technology segment captured the greatest dollar volume for the month.
...
In The Departments
Services
- Health Care Services
- Deal Summaries
- Additional Transactions
- Transaction Updates

Technology
- Health Care Technology
- Deal Summaries
Additional Transactions
- Transaction Updates

Sign up for a trial subscription and get the current issue!

Read more about The Health Care M&A Monthly.

Articles Archive

Companies Mentioned in this issue:
September 2006

A
A Carlsson Research AB p11
A.D.A.M., Inc. p12
ABN Amro p11
AccentCare p3
Access Therapeutics Infusion p3
Advent Partners p11
Airox, SA p12
Akrikhin p16
Alan James Group p9
Alticor, Inc. p9
American Capital Strategies p16
AmerisourceBergen p9
Amerita Healthcare p3
Anaheim Memorial Medical Center p3
Arsenal Capital Partners p16
Assurant p7
Astellas p11
Avidex, Ltd. p11
B
BD p12
Becton, Dickinson & Co. p12
Bingham McCutchen p7
Bio-Reference Laboratories p4
Blackstone Medical p12
Blum Capital p10
Braff Group p2
Broadspire Services p7
C
Canyon Creek Development p4
CapitalSource p12
CB Richard Ellis p4
Cedar Court Rehabilitation Hospital p8
Chartwell Seniors Housing REIT p4
Chiron Corp. p12
Citigroup p12
Citigroup Global Markets, Inc. p16
Close Brothers Private Equity p16
Community Health Systems p3
Concord Biotech Ltd. p10
Corus Pharma p12
Cowen and Company p12
Crawford & Co. p7
D
Deutsche Bank p9
Docpharma NV p10
DSP Merrill Lynch p11
E
Emdeon Corp. p12
Emdeon Practice Services p12
Epworth Foundation p8
Epworth Hospital p8
Explora Laboratories S.A. p10
F
Ferrer Freeman & Co. p3
Follas Laboratories p4
Forum Health p3
G
GeneDx p4
Genstar Capital, LLC p4
Gilead Sciences p12
Good Samaritan Community Healthcare p3
Gropep, Ltd. p11
Guilford Pharmaceuticals p16
H
Health Management Associates p2
HealthSouth p8
Holland Health Service p8
Huntington Beach Hospital p3
I
ING Management Limited p8
ING Real Estate Australia p4
Interleukin Genetics p9
Inverness Medical Innovations p16
J
JP Morgan Partners p12
K
Kemper Insurance Companies p7
Kindred Healthcare p9
Kindred Pharmacy Services p9
King & Spalding p7
King Pharmaceuticals p10
KRG Capital Partners p2
L
La Palma Intercommunity Hospital p3
Lake Worth Gardens p4
Lane, Berry & Co. p12
Legacy at Anderson p4
Lehman Brothers p9
LeisureCare Retirement Communities p4
Lincare p3
M
Madison Glen Properties p4
Marcus & Millichap p7
Martin Luther King Hospital p3
Matrix Laboratories, Ltd. p1
Mchem Group p10
Medicure p16
MediGene AG p11
Memorial Health Services p3
Merck & Co. p16
MGI Pharmaceuticals p16
MultiCare Health System p3
MultiPlan p7
Mylan Laboratories p1
N
NBTY, Inc. p9
NeuroSearch A/S p11
NewBridge Capital p10
Northside Medical Center p3
Novartis p12
Novozymes A/S p11
O
Occulogix p12
Odyssey p2
Omnicare p8
OnCURE Medical p4
Online Benefits p12
OribiMed Advisors, LLC p12
Orion Residential p4
Orthofix International p12
P
Pathologists Associated p4
Pediatric Services of America p3
PharMerica Long-Term Care p9
Platinum Equity p7
Preferred Hospice of Oklahoma p2
Prime Healthcare Services p3
Private Health Care Systems p7
Procter & Gamble Co. p16
Psychiatric Solutions p2
Q
Quester p11
R
Radiation Therapy Services p4
Ranbaxy Laboratories p16
Ranier Home Health Care Pharmacy p8
ResCare p2
Rosemont Pharmaceuticals, Ltd. p16
S
Sage Group plc p12
Sandy Pines p2
Savient Pharmaceuticals p16
Scientific Protein Laboratories p16
SOLX p12
Spandana Foundation p10
Standard Management Corp. p8
Starwood Capital Group p4
StoneRidge Advisors p7
Strides Arcolabs Ltd. p10
Sun Healthcare Group p2
SunPlus Home Health Services p3
Sunrise Senior Living p2
SunTrust Robinson Humphrey p7
Syngenta AG p11
T
Temasek Pte. Limited p10
Templeton Development Group p4
Tenet Healthcare Corp. p4
Teva p10
Texas Pacific Group p10
TLC Supported Living Services p2
TLC Supported Living Services of Kentucky p2
Trinity Hospice p2
TriPath Imaging p12
Trumbull Memorial p3
Tyco International p12
U
UBS Limited p11
University Behavioral Center p2
USC University Hospital p4
V
Vanguard Health Systems p3
Ventana Medical Systems p12
Vision Systems Ltd. p12
VistaCare p2
W
Wachovia Bank p12
West Anaheim Medical Center p3
Wyeth p16
Z
Zila, Inc. p9
Zila Nutraceuticals p9

The Month In Deals: August Posts 68 Deals Worth $4 Billion

Email Editor

The month of August saw a total of 68 mergers and acquisitions announced in 13 sectors of the health care industry. The month’s deal volume dropped ever so slightly from July’s tally of 69 deals. The nine sectors of the health care services segment accounted for 35 deals, or 51% of the month’s total, with the four technology sectors contributing the remaining 33 deals.

Among the individual sectors, Medical Devices led the pack with 15 deals, or 22% of August’s M&A activity. It was followed by Biotechnology with seven deals and Pharmaceuticals and Long-Term Care with six deals each. The Physician Medical Group sector posted just one transaction.

Based on prices revealed to date, a total of $4.0 billion was committed to finance the month’s 68 deals, down significantly from the $35.5 billion spent in July. The technology segment accounted for $3,297,275,500 and the services segment for the remaining $658,630,000.

For the second time this year (the first was February), no billion-dollar deals were announced. The largest deal, valued at $736 million, was posted in the Pharmaceutical sector.

FREE TRIAL TO THE
HEALTH CARE M&A INFORMATION SERVICE
!

If you like this article, there’s lots more waiting for you in The Healthcare M&A Information Service. It’s the bible of what's going on in health care M&A today.

Sign up for two free months right now! There’s no obligation, no writing “cancel” on a bill. Happy reading!

The Health Care M&A Monthly

First Name


Last Name

Company

Company Type

Address


Address2


City


State


ZipCode


Country


Email


Email (again, to verify)


Phone


Fax

To confirm this request please enter: headm


Submission may take a few seconds. Please click only once.

Like this article? Click here for a free trial to the Health Care M&A Information Service.

Back to top

 

 

Irving Levin Associates, Inc.,  268 1/2 Main Avenue, Norwalk, CT 06851
800-248-1668; 203-846-6800
203-846-8300 fax

general@levinassociates.com

Since 1948, Irving Levin Associates, Inc. has been the leading source of information and investment research on mergers and acquisitions in the Behavioral Health Care, Biotech, e-Health, Home Health Care, Hospitals, Laboratories, MRI and Dialysis, Long Term Care, Managed Care, Medical Devices, Pharmaceuticals, Physician Medical Groups, Rehabilitation and other health care markets.

More Irving Levin Information:
Mergers, Acquisitions and Healthcare Venture Capital Financing Research at Irving Levin Associates | Dealmakers Resource Center on Senior Care and Health Care Companies | Healthcare Marketing Research and Healthcare Finance Publications | Database of Healthcare Ventures, Mergers and Acquisitions | Free Trial Request For One Of Our Newsletters Customer Service at Irving Levin Associates | Publication Order Form | Press Room| Contact Us
 

© 1995-2008, Irving Levin Associates, Inc. All rights reserved.